These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3855433

  • 61. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
    Gidáli J, Fehér I, Kovács P.
    Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
    [Abstract] [Full Text] [Related]

  • 62. CD38 as a target of IB4 mAb carrying saporin-S6: design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia.
    Bolognesi A, Polito L, Farini V, Bortolotti M, Tazzari PL, Ratta M, Ravaioli A, Horenstein AL, Stirpe F, Battelli MG, Malavasi F.
    J Biol Regul Homeost Agents; 2005 Sep; 19(3-4):145-52. PubMed ID: 16602630
    [Abstract] [Full Text] [Related]

  • 63. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
    Mills KC, Gross TG, Varney ML, Heimann DG, Reed EC, Kessinger A, Talmadge JE.
    Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996
    [Abstract] [Full Text] [Related]

  • 64. Inhibition of human acute lymphoblastic leukemia cells by immunotoxins: potentiation by chloroquine.
    Ramakrishnan S, Houston LL.
    Science; 1984 Jan 06; 223(4631):58-61. PubMed ID: 6318313
    [Abstract] [Full Text] [Related]

  • 65. Interleukin-2 activation of human bone marrow in long-term cultures: an effective strategy for purging and generation of anti-tumor cytotoxic effectors.
    Verma UN, Bagg A, Brown E, Mazumder A.
    Bone Marrow Transplant; 1994 Feb 06; 13(2):115-23. PubMed ID: 8205079
    [Abstract] [Full Text] [Related]

  • 66. Host-mediated antibody-dependent cellular cytotoxicity contributes to the in vivo therapeutic efficacy of an anti-CD7-saporin immunotoxin in a severe combined immunodeficient mouse model of human T-cell acute lymphoblastic leukemia.
    Flavell DJ, Warnes S, Noss A, Flavell SU.
    Cancer Res; 1998 Dec 15; 58(24):5787-94. PubMed ID: 9865737
    [Abstract] [Full Text] [Related]

  • 67. Evidence for absence of toxicity of T101 immunotoxin on human hematopoietic progenitor cells prior to bone marrow transplantation.
    Douay L, Gorin NC, Lopez M, Casellas P, Liance MC, Jansen FK, Voisin GA, Baillou C, Laporte JP, Najman A.
    Cancer Res; 1985 Jan 15; 45(1):438-41. PubMed ID: 3880666
    [Abstract] [Full Text] [Related]

  • 68. In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
    Uckun FM, Manivel C, Arthur D, Chelstrom LM, Finnegan D, Tuel-Ahlgren L, Irvin JD, Myers DE, Gunther R.
    Blood; 1992 May 01; 79(9):2201-14. PubMed ID: 1373967
    [Abstract] [Full Text] [Related]

  • 69. Gamma-ray-induced cell killing and chromosome abnormalities in the bone marrow of p53-deficient mice.
    Wang L, Cui Y, Lord BI, Roberts SA, Potten CS, Hendry JH, Scott D.
    Radiat Res; 1996 Sep 01; 146(3):259-66. PubMed ID: 8752303
    [Abstract] [Full Text] [Related]

  • 70. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
    Bast RC, Ritz J, Lipton JM, Feeney M, Sallan SE, Nathan DG, Schlossman SF.
    Cancer Res; 1983 Mar 01; 43(3):1389-94. PubMed ID: 6337707
    [Abstract] [Full Text] [Related]

  • 71. A specific and potent immunotoxin composed of antibody ZME-018 and the plant toxin gelonin.
    Rosenblum MG, Murray JL, Cheung L, Rifkin R, Salmon S, Bartholomew R.
    Mol Biother; 1991 Mar 01; 3(1):6-13. PubMed ID: 1906286
    [Abstract] [Full Text] [Related]

  • 72. T cell depletion of human bone marrow using an oxidase-peroxidase enzyme immunotoxin.
    Ito H, Morizet J, Coulombel L, Stanislawski M.
    Bone Marrow Transplant; 1990 Dec 01; 6(6):395-8. PubMed ID: 2097007
    [Abstract] [Full Text] [Related]

  • 73. Lectin-binding properties of Burkitt's lymphoma cell lines: application to bone marrow purging.
    Mumcuoglu M, Favrot M, Slavin S.
    Exp Hematol; 1990 Jan 01; 18(1):55-60. PubMed ID: 2298270
    [Abstract] [Full Text] [Related]

  • 74. An immunotoxin with therapeutic potential in T cell leukemia: WT1-ricin A.
    Myers CD, Thorpe PE, Ross WC, Cumber AJ, Katz FE, Tax W, Greaves MF.
    Blood; 1984 May 01; 63(5):1178-85. PubMed ID: 6370334
    [Abstract] [Full Text] [Related]

  • 75. Favorable pharmacodynamic features and superior anti-leukemic activity of B43 (anti-CD19) immunotoxins containing two pokeweed antiviral protein molecules covalently linked to each monoclonal antibody molecule.
    Myers DE, Yanishevski Y, Masson E, Irvin JD, Evans WE, Uckun FM.
    Leuk Lymphoma; 1995 Jun 01; 18(1-2):93-102. PubMed ID: 8580835
    [Abstract] [Full Text] [Related]

  • 76. Selective cytotoxicity of murine monoclonal antibody LAM2 against human small-cell carcinoma in the presence of human complement: possible use for in vitro elimination of tumor cells from bone marrow.
    Stahel RA, Mabry M, Sabbath K, Speak JA, Bernal SD.
    Int J Cancer; 1985 May 15; 35(5):587-92. PubMed ID: 2987136
    [Abstract] [Full Text] [Related]

  • 77. Selective cytotoxicity of the SM1 monoclonal antibody towards small cell carcinoma of the lung.
    Bernal SD, Mabry M, Stahel RA, Griffin JD, Speak JA.
    Cancer Res; 1985 Mar 15; 45(3):1026-32. PubMed ID: 2982482
    [Abstract] [Full Text] [Related]

  • 78. In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against BCL-1 murine B-cell leukemia.
    Uckun FM, Chelstrom LM, Irvin JD, Finnegan D, Gunther R, Young J, Kuebelbeck V, Myers DE, Houston LL.
    Blood; 1992 May 15; 79(10):2649-61. PubMed ID: 1375109
    [Abstract] [Full Text] [Related]

  • 79. Effects of cytostatic drugs and 40.5 degrees C hyperthermia on human bone marrow progenitors (CFU-C) and human clonogenic tumor cells implanted into mice.
    Neumann HA, Fiebig HH, Löhr GW, Engelhardt R.
    J Natl Cancer Inst; 1985 Dec 15; 75(6):1059-66. PubMed ID: 2999496
    [Abstract] [Full Text] [Related]

  • 80. Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials.
    Myers DE, Irvin JD, Smith RS, Kuebelbeck VM, Uckun FM.
    J Immunol Methods; 1991 Feb 15; 136(2):221-37. PubMed ID: 1705571
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.